Massachusetts Lawmakers Prioritize Health Policy
Katherine O'Malley
August 12, 2026
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Cause evidently I have nothing better to do, I answered my own question. Here’s a chart I made of HPV vaccination rates in adolescent females by
New data on vaccination rates among 13-17-year-olds have been released by the CDC. In 2014, more than 87% of adolescents had received at least one
I’ve long been concerned about implementing public health policy without really studying it. Sometimes, it’s because I worry the policy won’t work. Sometimes, it’s because
The following originally appeared on The Upshot (copyright 2015, The New York Times Company). In the last few years, I’ve watched a continuing battle among my friends
Harold Pollack, Timothy Jost, and I have a piece in The American Prospect about why we need Medicaid and how we should improve it. We
In Austin’s and my ongoing crusade to restore researchers’ access to substance-use data from Medicare and Medicaid, we’ve pinned our hopes on the Substance Abuse
Online in JAMA Pediatrics today, “Epidemiologic Trends in Neonatal Intensive Care, 2007-2012“: Importance Neonatal intensive care has been highly effective at improving newborn outcomes but
In a well-referenced paper, Sherry Glied and Erin Miller summarized the history of health economics research and its policy impact, with emphasis in the second half
“Female Viagra” and regular or “male” Viagra were both originally investigated as treatments for conditions other than sexual dysfunction. Viagra came out of studies on
Read, or nearly: Sapiens: A Brief History of Humankind, by Yuval Noah Harari—At over 400 pages, it’s not that brief, but it’s worth it. It’s my
Brad Flansbaum drew my attention to this testimony before the House Ways and Means Committee by Mark Miller, Executive Director of the Medicare Payment Advisory